DUBLIN, April 18, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Viral Clearance Market by Application, Method (Inactivation, Removal, Detection (PCR, ELISA)) & End User - Global Forecast to 2020 " report to their offering.
The global viral clearance market was valued at USD 285.5 Million in 2015. This market is expected to grow at a CAGR of 12.3% to reach USD 510.3 Million in 2020.
The global viral clearance market is segmented on the basis of method, end user, application, and geography. Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this market. For instance, the number of new biologics products launched annually witnessed a strong upward trend between 2003 and 2013.
The number of new products launched in 2013 was 56 as compared to 29 in 2003. The biologics pipeline has increased by 155%, from 355 treatments in 2001 to 907 in 2012. A strong pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology industry, which is an important end user of viral clearance products.
Moreover, increasing government support for the pharmaceutical and biotechnology industries will further boost the demand for viral clearance products. For instance, in 2013, the European Research Council awarded a fund of USD 830 million for life sciences research projects across Europe. A similar trend can be observed in Asia. For instance, beginning in 2014, the Indian government plans to invest up to USD 5 billion a year for the next five years, to boost the biotechnology sector in the country and make it a USD 100 billion industry by 2025. These funding activities help in increasing the purchasing power of major research institutes, which in turn is driving the market for viral clearance products.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Viral Clearance Market, By Application
7 Viral Clearance Market, By End User
8 Viral Clearance Market, By Method
9 Viral Clearance Market, By Region
10 Competitive Landscape
11 Company Profiles
- Avance Biosciences Inc.
- Bsl Bioservice
- Charles River Laboratories International, Inc.
- Clean Cells Inc.
- Lonza Group
- Merck Kgaa
- Sgs S.A.
- Sigma-Aldrich Corporation
- Texcell, Inc.
- Wuxi Pharmatech (Cayman) Inc.
For more information visit http://www.researchandmarkets.com/research/b4mk3t/viral_clearance
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets